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Crystals of the Saccharomyces cerevisiae pyrimidine biosynthetic
enzyme orotidine 50-phosphate decarboxylase (ODCase) were grown
by the hanging-drop vapor-diffusion technique at 277 K using
polyethylene glycol 4000 as the precipitant. Crystals of native and
selenomethionyl ODCase diffract to less than 2.2 AÊ and belong to the
orthorhombic space group P212121, with unit-cell parameters a = 90.1,
b = 116.2, c = 117.0 AÊ . Crystals of ODCase grown in the presence of
the postulated transition-state analog inhibitor 6-hydroxyuridine
50-phosphate (BMP) diffract to less than 2.5 AÊ and belong to space
group P21, with unit-cell parameters a = 79.9, b = 80.0, c = 98.2 AÊ ,
 = 108.6.
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1. Introduction
Orotidine 50-phosphate decarboxylase
(ODCase; E.C. 4.1.1.23) catalyzes the ®nal step
in de novo pyrimidine biosynthesis yielding
uridine 50-phosphate (UMP), an essential
precursor for synthesis of nucleic acids. In
eukaryotes, orotate phosphoribosyltransferase
(OPRTase; E.C. 2.4.2.10) and ODCase
comprise separate catalytic domains of the
bifunctional enzyme UMP synthase. However,
in fungi and bacteria these enzymes exist as
independent monofunctional dimeric proteins
(Yablonski et al., 1996). Compounds that are
ODCase inhibitors impair biosynthesis of
nucleic acids in all cell types and several have
been tested as potential anticancer agents
without success (Handschumacher et al., 1962;
Sweeney et al., 1973). One of the most potent
ODCase inhibitors is 6-hydroxyuridine
50-phosphate (BMP; Ki = 9  10ÿ12 M), a
compound which resembles the postulated
intermediate generated in the transition state
during OMP decarboxylation (Levine et al.,
1980).
The spontaneous loss of CO2 from OMP is
an extremely slow reaction that proceeds with
a half-time of nearly 7.8  107 y in aqueous
solutions at 298 K (Radzicka & Wolfenden,
1995). Despite numerous studies involving
model decarboxylation reactions (Beak &
Siegel, 1976; Silverman & Groziak, 1982; Lee
& Houk, 1997), the mechanism employed by
ODCase remains a mystery. In contrast to
other enzymatic decarboxylations, ODCase is
unique in that it appears to function indepen-
dently of known cofactors and metals (Shostak
& Jones, 1992; Miller et al., 1999) while
enhancing the spontaneous rate of OMP
decarboxylation by nearly 17 orders of
magnitude. Thus, structural studies of ODCase
provide a source of new information that
should enhance understanding of this enzyme's
reaction mechanism. Here, we describe crys-
tallization conditions for recombinant yeast
ODCase, free and in complex with
6-hydroxyuridine 50-phosphate, and present
initial X-ray diffraction results for both the
native and selenomethionine-substituted
enzymes.
2. Materials and methods
Native recombinant yeast ODCase was
expressed in Escherichia coli strain SS6130 and
Figure 1
Photograph of native ODCase crystals grown at 277 K.
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puri®ed as described previously (Miller et
al., 1999). Prior to its expression in E. coli,
the AGA and AGG arginine codons of the
yeast ura3 gene were changed to CGC or
CGU. Stock solutions of puri®ed ODCase
(18±25 mg mlÿ1) were stored at 253 K in
50 mM Tris±HCl (pH 7.0) containing 5 mM
-mercaptoethanol and 5% glycerol. Protein
concentration was estimated from the
absorbance at 280 nm using a calculated
molar extinction coef®cient of 28 830 cmÿ1
(Edelhoch, 1967).
Selenomethionyl ODCase was prepared
by growing SS6130 (pBGM88) in a minimal
media containing Vogel and Bonner salts
(Vogel & Bonner, 1956), 0.002% vitamin B1,
0.6% glycerol and 150 mg mlÿ1 ampicillin. To
this solution, sterile amino acids were added
to give the following ®nal concentrations:
dl-selenomethionine, 120 mg mlÿ1; alanine,
glycine, serine and threonine, 0.5 mg mlÿ1;
arginine, 0.6 mg mlÿ1; asparagine, aspartate,
glutamine and lysine, 0.4 mg mlÿ1; cysteine,
0.03 mg mlÿ1; glutamate, 0.7 mg mlÿ1; histi-
dine and proline, 0.1 mg mlÿ1; isoleucine,
leucine and valine, 0.25 mg mlÿ1; phenyl-
alanine, 0.15 mg mlÿ1; tryptophan and tyro-
sine, 0.2 mg mlÿ1. The expression cultures
were inoculated to an initial OD600 of 0.005
and incubated at 300 K for 19±24 h, after
which the OD600 was 4.5. ODCase from
bacteria grown in selenomethionine medium
was puri®ed to greater than 95% homo-
geneity using the same conditions employed
for puri®cation of the native protein.
Analysis of the selenomethionyl enzyme by
electrospray mass spectrometry showed that
all six methionine residues per subunit were
replaced by selenomethionine.
Crystals of native ODCase
were grown at 277 K by the
hanging-drop vapor-diffusion
method using 0.1 M Na HEPES
pH 7.0, 10%(v/v) 2-propanol and
20%(w/v) polyethylene glycol
4000 as the precipitant. The
protein drops were prepared by
adding 2 ml of ODCase solution
to 3 ml of the reservoir solution.
Crystals of native protein typi-
cally appeared overnight. Prior to
data collection, the crystals were
equilibrated in a cryoprotectant
composed of 0.085 M Na HEPES
pH 7.0, 8.5%(v/v) 2-propanol,
17%(w/v) polyethylene glycol
4000, 15% glycerol (Hampton
Cryo #41). Crystals of seleno-
methionine-substituted ODCase
were grown as described for the
native enzyme except that these
crystals required incubation for
6±10 d at 277 K. Diffraction data for native
crystals were collected at 93 K on a Rigaku
RU-200 rotating-anode generator equipped
with an MSC R-AXIS 4 area detector.
Crystals of ODCase grown in the
presence of BMP were obtained at 295 K in
0.18 M NaH2PO4, 18%(w/v) PEG 3350. The
hanging drops contained 8 mg mlÿ1 enzyme
and BMP added in a 2.7:1 molar ratio.
Crystals generally appeared after 7±10 d and
were equilibrated in cryoprotectant
containing 0.18 M NaH2PO4, 18%(w/v)
PEG 3350, 25%(v/v) glycerol prior to data
collection.
3. Results and discussion
Screening for optimal crystallization condi-
tions was performed using sparse-matrix
sampling (Jancarik & Kim, 1991; Crystal
Screens I and II, Hampton Research) at
temperatures in the range 277±295 K. Single
crystals of native recombinant yeast
ODCase (0.74  0.66  0.37 mm) were
obtained from hanging drops incubated
overnight at 277 K (Fig. 1). The diffraction
pattern shown in Fig. 2 represents a typical
10 min, 1.5 oscillation image obtained with
crystals of native enzyme. These crystals
diffracted to less than 2.0 AÊ resolution, were
orthorhombic and belonged to the space
group P212121, with unit-cell parameters
a = 90.1, b = 116.2, c = 117.0 AÊ . Assuming a
protein density of 2.3 AÊ Daÿ1 and a solvent
content of 40%, there are four molecules per
asymmetric unit (Matthews, 1968). In
general, ODCase crystals remained stable
on storage at 277 K for six months without
loss in resolution.
Replacement of all six ODCase methio-
nine residues with selenomethionine did not
appear to change the physical properties of
this protein. The selenomethionyl enzyme
had a speci®c activity that did not differ
noticeably from the activity of the native
enzyme. Crystals of the selenomethionyl
protein were grown under the same crys-
tallization conditions as de®ned for the
native enzyme. However, these crystals were
much slower to develop and were markedly
smaller than those of the native enzyme.
Attempts to increase crystal size by micro-
seeding or to obtain crystals under different
conditions were not successful.
The mechanism of enzymatic OMP
decarboxylation has to date eluded de®ni-
tion. Our initial approach to the study of this
reaction involves de®ning those enzyme
residues that might participate in catalysis
owing to their juxtaposition to the proposed
transition-state analog inhibitor BMP
(Ki = 9  10ÿ12 M; Brody & Westheimer,
1979). To this end, structural studies were
initiated on ODCase complexed with BMP.
Crystals of ODCase (270 mM in subunits)
grown in the presence of excess BMP
(740 mM) belonged to the space group P21,
with unit-cell parameters a = 79.9, b = 78.0, c
= 98.2 AÊ ,  = 108.6, suggesting that these
crystals represent the enzyme±ligand
complex. These crystals diffracted to less
than 2.5 AÊ and contained four ODCase
monomers per asymmetric unit.
Our ability to grow ODCase crystals was
aided by the original crystallization studies
of yeast ODCase complexed with BMP (Bell
et al., 1991); however, the crystallization
conditions and crystal space groups differed
dramatically between the two studies. This
lack of similarity may be because of physical
differences between ODCase puri®ed from
yeast and the recombinant yeast enzyme
expressed in and puri®ed from bacteria
(Miller et al., 1999). Diffraction data
collected for selenomethionyl ODCase and
the native enzyme complexed with BMP are
currently being analyzed. The ability to
generate diffraction-quality crystals offers
hope that the structures of free and liganded
ODCase will be determined, thereby
providing an understanding of the forces
responsible for this enzyme's remarkable
catalytic capabilities.
We thank Jennifer Neugebauer for
conducting mass-spectrometric analysis of
native and selenomethionine-substituted
ODCase. This work was supported in part by
NIH Training Grant GM-08570.
Figure 2
A 1.5 oscillation image of a crystal of native ODCase. The crystals
diffract nominally to 2.0 AÊ .
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